CSIMarket
 
LUDWIG ENTERPRISES, INC.  (OTC: LUDG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Ludwig Enterprises's Customers Performance

LUDG



 
LUDG's Source of Revenues

• List of LUDG Customers




for the same period Ludwig Enterprises, Inc.

• List of LUDG Customers





Ludwig Enterprises's Comment on Sales, Marketing and Customers



The company employs a multi-channel commercialization strategy targeting business-to-business-to-consumer (B2B2C) relationships, partnerships with employers, captive insurers, and commercial and public payors for reimbursement. Its initial product, the Revealia™ Breast test, is scheduled for commercial launch in the second quarter of 2026. The company plans to utilize institutionally enabled access pathways, including healthcare providers and clinically affiliated channels, to facilitate test availability, while also offering consumer-paid testing kits in select cases. The strategy includes securing reimbursement coverage, publishing peer-reviewed data, expanding its network of CLIA-certified and CAP-accredited laboratories, and increasing awareness through digital marketing, educational outreach, and physician engagement. The focus is on early cancer detection to align with payer incentives aimed at managing costs and improving patient outcomes.





Ludwig Enterprises’s Comment on Sales, Marketing and Customers


The company employs a multi-channel commercialization strategy targeting business-to-business-to-consumer (B2B2C) relationships, partnerships with employers, captive insurers, and commercial and public payors for reimbursement. Its initial product, the Revealia™ Breast test, is scheduled for commercial launch in the second quarter of 2026. The company plans to utilize institutionally enabled access pathways, including healthcare providers and clinically affiliated channels, to facilitate test availability, while also offering consumer-paid testing kits in select cases. The strategy includes securing reimbursement coverage, publishing peer-reviewed data, expanding its network of CLIA-certified and CAP-accredited laboratories, and increasing awareness through digital marketing, educational outreach, and physician engagement. The focus is on early cancer detection to align with payer incentives aimed at managing costs and improving patient outcomes.








LUDG's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
LUDWIG ENTERPRISES, INC. 3.46 0.00 -1.47 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: LUDWIG ENTERPRISES, INC.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: LUDWIG ENTERPRISES, INC.’s corporate clients.
For your research, we’ve provided 9 tables on LUDWIG ENTERPRISES, INC. corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.